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Purpose: To compare the incidence of radiocontrast-induced nephropathy (RCIN) in patients 
undergoing coronary angiography pretreated with N-acetylcysteine NAC plus saline hydration or saline 
hydration alone and to determine the association between various risk factors and RCIN.  
Methods: Patients were retrospectively evaluated over a one-year period. RCIN was defined as an 
acute rise in serum creatinine of at least 0.5 mg/dl or more than 25 % from baseline value. SPSS 
software, version 13 was used for data analysis. 
Results: Overall, 299 patients were studied. Thirteen patients (4.3%) developed RCIN. RCIN was 3.3 % 
in patients treated with hydration, and 8.3 % in patients treated with NAC plus hydration (p = 0.09). In 
patients with RCIN, the changes in creatinine and % change in creatinine after 24 h were significantly 
lower  in the NAC plus hydration group (p = 0.039 and p = 0.042, respectively). RCIN was significantly 
associated with male gender (p = 0.017), history of renal failure (p = 0.006), ischemic heart disease (p = 
0.003), and diuretic treatment (p = 0.013).   
Conclusion: NAC plus saline hydration may not be more effective than saline hydration alone in 
decreasing RCIN after coronary angiography. Additional efforts to find an ideal preventive treatment are 
needed.  
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INTRODUCTION 
 
Coronary angiography is the test that requires the 
administration of a radiocontrast medium to reveal 
the location and degree of coronary stenosis or 
obstruction due to plaque formation. This 
radiocontrast medium (usually iodine-based) can 
contribute to the development of nephropathy [1].  
 
Radiocontrast-induced nephropathy (RCIN) is 
defined as the acute deterioration of renal function 
that occurs two to seven days after administration 
of radiocontrast media in the
 
absence of other 
causes [2]. It is associated with increased morbidity 
and mortality [3], as well as increased health care 
costs [4]. There are many identified risk factors for 
RCIN, the most common ones being pre-existing
 
renal insufficiency and diabetes [5]. 
 
Hydration (using solutions such as isotonic saline, 
half-isotonic saline, dextrose solution, and sodium 
bicarbonate) remains the cornerstone for 
preventing RCIN [6]. N-acetylcysteine (NAC) is 
another potential option that reduces RCIN. NAC, 
a thiol-containing antioxidant, is thought to act 
either as a free-radical scavenger or as a reactive 
sulfhydryl compound that increases the reducing 
capacity of the cell [7]. It also combines with nitric 
oxide to form S-nitrosothiol, which is a more stable 
compound and is also a potent vasodilator [8]. 
 
A previous study had illustrated the protective 
effects of NAC as an adjunct to saline hydration 
against RCIN in low-risk patients [8]. However, 
contradictory results regarding effectiveness of 
NAC have been reported, and the protective effect 
of NAC is unclear [9, 10].  In Malaysia, data on the 
use of NAC in patients undergoing coronary 
angiography are lacking. Furthermore, the incidence 
and prevalence of RCIN in local hospitals have not 
yet been reported. This retrospective study was 
conducted with the following aims: 1) to compare 
the incidence of RCIN in patients undergoing 
coronary angiography after pretreatment with NAC 
plus standard saline hydration versus standard 
saline hydration alone, and 2) to determine the 
association between various risk factors and the 
occurrence of RCIN.  
 
SUBJECTS AND METHODS 
 
Settings and Study Design 
 
This was a retrospective cohort study of all 
patients admitted to Penang General Hospital, 
Penang, Malaysia, who underwent coronary 
angiography and received standard saline 
hydration alone or in combination with NAC as a 
preventive treatment. The Penang General 
Hospital, the largest public hospital in Penang, 
Northern Malaysia, is a 1,200-bed general hospital 
run by the Ministry of Health of Malaysia. Approval 
from the health authorities was obtained before 




Patients were conveniently sampled from July 
2006 until June 2007 from the Interventional 
Catheterization Lab (ICL). They were identified 
through a record book maintained by the staff at 
ICL. The record book kept details of patients who 
had undergone various diagnostic or interventional 
cardiology procedures. Sample size was 
calculated using a free software developed by the 
Department of Biostatistics, Vanderbilt University, 
USA (PS: Power and Sample Size Calculation 
version 3.0). These data were entered into the 
database to calculate sample size, and examine 
dichotomous outcomes (nephropathy versus no 
nephropathy): α = 0.05, power = 0.9, P0 = 0.1, P1 = 
0.3, M = 1. The calculated sample size was 62 
patients for each group. Furthermore, during the 
one-year study, 512 medical records were 
screened, but only 299 records were found to be 
complete for further evaluation. Sixty patients were 
prophylactically treated with NAC and hydration. 
The remaining 239 patients were treated with 
prophylaxis hydration for the prevention of RCIN. 
Patients were excluded if they were below the age 
of 18; if they had undergone other coronary 
procedures besides angiography, such as 
coronary stenting and bypass grafting; or if their 




Data were collected using special data collection 
forms and classified into several categories 
including the following: age; gender; ethnicity; 
weight; height; body mass index; past medical 
history; smoking; medical condition; current 
medications; renal profile at 24, 48, 72 and 96 h 
after radiocontrast media exposure; and 
radiocontrast media volume. In all cases, 
iopromide (Ultravist
®
), which is a nonionic, low-
osmolar contrast medium, was used. 
 
Radiocontrast-induced nephropathy was defined 
as an acute rise in serum creatinine of at least 0.5 
mg/dl (44 µmol/L) or more than 25 % from 
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baseline value [11]. Creatinine clearance (CrCl) 
was determined for each patient and was 
calculated using the Cockcroft-Gault formula, 
where CrCl = ([140 - age] × weight (kg) / serum 
creatinine (mg/dl) × 72), with adjustment for 
female sex (CrClfemale = CrCl × 0.85) [12]. Further, 
the Mehran risk score was estimated; this score 
reflects the risk of contrast nephropathy before the 
procedure. The Mehran risk score was calculated 
according to several risk factors, including 
baseline creatinine clearance, dose of contrast 
media, older age, hypotension, anemia, heart 
failure, diabetes, and the use of an intra-aortic 




The data were entered and analyzed using 
Statistical Package for Social Sciences, version 13 
(SPSS Inc., Chicago, Illinois) for Windows. 
Continuous variables were expressed as mean (± 
standard deviation), and categorical data were 
expressed as frequency and percentage. 
Variables that were not normally distributed were 
expressed as median (lower–upper quartiles). 
Comparisons between two variables that were 
normally distributed were carried out using the 
independent sample t-test. Variables were tested 
for normality using the Kolmogorov–Smirnov test; 
if assumptions of the equality of variance and 
normality were not met, the Mann-Whitney U test 
was performed as appropriate. Categorical 
variables were analyzed using the Chi-Square test 
or Fisher’s exact test, Fisher’s exact test was used 
in analyzing the 2 x 2 tables with an expected cell 
frequency of < 10. Probability values of < 0.05
 






A total of 299 patients were evaluated in this study; 
239 (79.9 %) patients received standard saline 
hydration alone, and 60 (20.1 %) patients received 
standard saline hydration plus NAC as a 
preventive treatment. 
 
Table 1 compares the baseline demographic and 
clinical characteristics of patients among both 
groups and shows that patients in the NAC plus 
standard saline hydration group had significantly 
lower creatinine clearance (p < 0.001), higher 
serum creatinine (p < 0.001), as well as higher 
prevalence of renal insufficiency (p = 0.035), 
diabetes mellitus (p = 0.012) , anemia (p = 0.012)   
and hypertension (p = 0.001). Using the Mehran 
Score, patients in the NAC plus standard saline 
hydration group were significantly more likely to be 
at moderate to high risk of developing RCIN than 
patients in the standard saline hydration group (p 
= 0.001); in contrast, patients in the standard 
saline hydration were more likely to be at low risk 
of developing RCIN (p < 0.001).   
 
Incidence of RCIN among both groups  
 
The overall incidence of RCIN was 4.3 % (13 of 
299) in the study population. RCIN was detected 
in eight of the 239 patients (3.3 %) in the standard 
saline hydration group and five of the 60 patients 
(8.3 %) in the NAC plus standard saline hydration 
group. There was no significant difference in the 
development of RCIN between the two groups (p = 
0.09). 
 
In the standard saline hydration group, RCIN 
developed after radiocontrast media exposure 
within 24 h in five patients, within 48 h in two 
patients, and within 96 h in a single patient. In the 
NAC plus hydration group, RCIN developed after 
radiocontrast media exposure within 24 h in three 
patients, within 72 h in one patient, and within 96 h 
in another patient.  
 
Comparison of creatinine-related markers of 
RCIN among the two groups  
 
Table 2 shows that the changes in serum 
creatinine (p = 0.039) and in percent serum 
creatinine level (p = 0.042) after 24 h were smaller 
in the NAC plus standard saline hydration group 
than the standard saline hydration group. Also, 
there were significant differences between the two 
groups regarding the changes in creatinine level 
48 h after radiocontrast media administration (p = 
0.008).  
 
Risk factors associated with the development of 
RCIN 
 
The results of analysis of demographic, clinical 
characteristics and other risk factors of 299 
patients according to the occurrence of RCIN are 
shown in Table 3. In comparison to patients who 
did not develop RCIN, patients who developed 
RCIN were more likely to be male (p = 0.017), 
have a history of renal failure (p = 0.006) or 
ischemic heart disease (p = 0.003), and be on 
diuretics (p = 0.013).   
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Table 1: Demographic and baseline clinical characteristics of the patients in the standard saline hydration 
group and the standard saline hydration plus NAC group 
  
Baseline characteristics Standard saline hydration 
group (N= 239) 
NAC+ standard saline 













































 26.1 ± 7.1 26.6 ± 3.9 0.132 
Active smoking status, n (%)
b
 54 (22.6%) 13 (21.7%) 0.878 
Contrast dose (mL) 
a
 53.5 ± 24.5 55.0 ± 29.6 0.346 
Creatinine clearance (mL/min)
 




74.9 (58.5 - 91.5) 
 









87 (78 – 101)   
 
135 (120.5 – 152) 
 
<0.001  
Contrast nephropathy risk score 
b#
 
≤ 5 (low) 
6-10 (moderate) 
11-16 (high) 
















Medical conditions     
Hypertension, n (%)
b
 179 (74.9%) 56 (93.3%) 0.001 
Diabetes mellitus, n (%)
b
 114 (47.7%) 39 (65%) 0.012 
Hyperlipidemia, n (%)
b
 139 (58.2%) 40 (66.7%) 0.229 
Renal insufficiency, n (%)
b
 10 (4.2%) 21 (35%) 0.035 
Ischemic heart disease, n (%)
b
 105 (43.9%) 25 (41.7%) 0.214 
Congestive heart failure, n (%)
b
 106 (44.4%) 28 (51.7%) 0.747 
Anemia, n (%) ¥ 3 (1.3%) 4 (6.7%) 0.015 
Medications    
ACEI/ARB, n (%)
b
 151 (63.2%) 40 (68.3%) 0.552 
Antiplatelets, n (%)
b
 226 (94.6%) 54 (90%) 0.318 
Diuretics, n (%)
b
 78 (32.6%) 24 (40%) 0.355 
BB, n (%)
b
 188 (78.7%) 47 (78.3%) 0.904 
CCB, n (%)
b
 38 (15.9%) 14 (23.3%) 0.242 
Statins, n (%)
b
 186 (77.8%) 50 (83.3%) 0.557 
Oral anti-diabetics, n (%)
b
 145 (60.7%) 45(75%) 0.056 
 
NAC = N-acetylcysteine, BMI = body mass index, ACEI = angiotensin-converting enzyme inhibitor, ARB = angiotensin 
receptor blocker, BB = β-blocker, CCB = calcium channel blocker, Q1 – Q3 = lower quartile to upper quartile, # Using 
Mehran risk score, 
a
 Significance of differences estimated with Student’s t-test;  
b
 Significance of differences estimated with Chi square test; 
c






The present study was conducted to investigate 
and compare the occurrence of RCIN among 
patients undergoing coronary angiography after 
pretreatment with standard saline hydration alone 
or standard saline hydration plus NAC as a 
preventive measure against RCIN. 
 
In this study, RCIN was identified in 13 patients, 
making the incidence of RCIN among hospitalized 
patients undergoing coronary angiography in our 
study 4.3 %.  This  result  was  consistent  with the 
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Table 2: Comparison of surrogate markers related to radiocontrast-induced nephropathy among the two 
groups 
 
 Standard saline 
hydration group 
(N=239) 
Median (Q1 –Q3) 
NAC + standard saline 
hydration group (N=60) 
Median (Q1 – Q3) 
P-value  
Serum creatinine at 24 h (µmol/L) 88 (79.0 - 103.3)   128 (122 -153) < 0.001 
∆ Creatinine at 24 h (µmol/L) 1.2 -2.1 0.039 
∆ Creatinine at 24 h (%) 1.3 -0.6  0.042 
Serum creatinine at 48 h (µmol/L) 89 (76 - 101) 129 (116 – 144) < 0.001 
∆ Creatinine at 48 h (µmol/L) 0.8 -5.0 0.008 
∆ Creatinine at 48 h (%) 0.8 -2.6  0.188 
Note: ∆ =  change, NAC = N-acetylcysteine,  Q1 – Q3 =  lower quartile to upper quartile; Significance of all 
differences estimated with Mann–Whitney U-test. 
 
reported incidence of RCIN in the general 
population, which ranges from 1 to 6 % [14,15].   
 
It was found that there were no differences 
between hydration with standard saline alone and 
hydration with standard saline plus NAC in 
protecting against the development of RCIN. 
Radiocontrast-induced nephropathy occurred in 
3.3 % of patients in the standard saline hydration 
group and 8.3 % of patients in the NAC plus 
standard saline hydration group (p = 0.09). The 
higher incidence of diabetes, renal insufficiency, 
and other risk factors in the NAC plus standard 
saline hydration group may clarify the higher 
incidence of RCIN in this group. Moreover, those 
risk factors, i.e., hypertension, diabetes and renal 
insufficiency that showed significantly higher 
incidence among patients in NAC plus hydration 
group may explain the non-significance in the 
development of RCIN between the two groups. 
Furthermore, this result is consistent with previous 
a study that found that there was no benefit in 
adding NAC to standard hydration, in 
comparison to standard hydration by itself, for 
preventing RCIN among patients undergoing 
coronary angiography [16].  
Patients in the NAC plus standard saline hydration 
group had higher median serum creatinine levels 
documented at 24 h than patients in the standard 
saline hydration group. This result may be be due to 
the fact that patients in the NAC plus standard 
saline hydration group had significantly higher renal 
insufficiency risk factor at baseline, compared to the 
standard saline hydration (p = 0.035)  . However, as 
estimated from the median change in serum 
creatinine, patients in the NAC plus standard saline 
hydration group, overall, had a greater reduction in 
percent serum creatinine, compared to the standard 
saline hydration alone group (p = 0.042).  
 
The prophylactic oral administration of the 
antioxidant NAC to patients with renal impairment 
has been examined on the assumption that reactive 
oxygen species are involved in RCIN. However, a 
prospective, double-blind, placebo controlled, 
randomized clinical trial, concluded that there was 
no detectable derivable benefit from the 
prophylactic administration of oral NAC over an 
aggressive hydration protocol in patients with 
diabetes mellitus and chronic kidney disease [10]. 
Also, another clinical study reviewed by Fishbane et 
al showed mixed results [9].  Therefore, the use of 
NAC, although not recommended for all patients, 
may be appropriate for patients at very high risk of 
RCIN [17]. 
 
The present study showed that RCIN was 
associated with male gender, a history of renal 
failure, ischemic heart disease, and previous 
diuretics treatment. Limited data exist to determine 
the relative impact of gender on the development 
of RCIN. An American study showed that females 
are at a higher risk of developing RCIN after 
radiocontrast exposure [18], but such findings were 
thought to be the result of confounding factors such 
as age, and the presence of other risk factors, such 
as anemia among female patients. This could have 
made females appear to be at greater risk for 
developing RCIN. More women than men in all 
quartiles were found to have stage 2 chronic 
kidney disease before angiography [18]. Our  
findings showed that RCIN occurred in male 
patients only, probably because in both groups, 
there were more male patients than female 
patients and the male patients were at higher risk 
to develop RCIN than female patients. Although 
diabetes mellitus and renal disease have been 
clearly identified as risk factors for the 
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Table 3: Demographic, risk factors and clinical characteristics by categories for patients who develop or 
didn’t develop RCIN  
  




(N= 13) ; (%) 
Non-RCIN 
patients 
(N= 286) ; (%) 
p-value 
Age a 
≥ 70 years 
















































































Contrast nephropathy risk #a 
High risk patient 












Volume of radiocontrast media a 
≥ 100 mL 













Diabetes mellitus presenta  153 (51.2) 9 (69.2) 144 (50.4) 0.258 
Renal insufficiency present a  31 (10.4) 5 (38.5) 26 (9.1) 0.006 
Heart failure present a 134 (44.8) 5 (38.5) 129 (45.1) 0.638 
Ischemic heart disease present b 130 (43.5) 11 (84.6) 119 (41.6) 0.003 
Hyperlipidemia present b 179 (59.9) 2 (15.4) 177 (61.9) 0.001 
Hypertension present b 235 (78.6) 7 (53.8) 228 (79.7) 0.026 
Anemia present a 7 (2.3) 1 (7.7) 6 (2.1) 0.27 
ACEI + ARB present a 179 (59.9) 8 (61.5) 171(59.8) 0.899 
CCB presenta 52 (17.4) 4 (30.8) 48(16.8) 0.193 
Statins present a 236 (78.9) 10 (76.9) 226(79) 0.74 
Diuretics present a 102 (34.1) 9 (69.2) 93(32.5) 0.013 
Note: RCIN = radiocontrast-induced nephropathy; ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin 
receptor blocker;  CCB = calcium channel blocker; 
#
 Using Mehran risk score; 
a 
Significance of differences estimated with 
Fisher’s exact test; 
b
 Significance of differences estimated with Chi square test 
 
development of RCIN [19], less emphasis has 
been placed on other diseases that may be 
important risk factors.   
 
All prescription medications used in all the patients 
undergoing coronary angiography had been 
withheld for at least 12 - 24 h prior to the 
procedure. The present study showed that 
previous diuretic use was associated with the 
development of RCIN. A previous study has 
reported that nephrotoxic medication, such as 
aminoglycosides and furosemide, as well as drugs 
that impair renovascular autoregulation, such as 
non-steroidal anti-inflammatory drugs and 
angiotensin-converting enzyme inhibitors, were 
risk factors for the development of RCIN [20].  
 
Limitations of the study 
 
One of the limitations of this study is the 
retrospective nature of the study itself. Therefore, 
this study lacks the ability to investigate variables 
that were missing from the data in the medical 
records. Another limitation is the differences in the 
baseline characteristics between the patients 
treated with standard saline hydration plus NAC 
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and patients receiving standard saline hydration 
alone. These factors may confound the 
relationship between the treatment with NAC and 
the occurrence of RCIN. Finally, our data are 
limited to four days after the procedure. The onset 
of RCIN may occur later. Thus, measuring renal 
function within four days of the procedure may 
have underestimated the nephropathy risk. 
 
CONCLUSION   
 
Hydration with standard saline plus oral NAC 
before radiocontrast medium exposure may not be 
more effective than hydration with standard saline 
alone for prophylaxis of RCIN in patients 
undergoing coronary angiography. According to 
the online database from the National Medical 
Research Register of Malaysia, there is currently 
no registered research pertaining to this issue. 
Further Malaysian perspectives and multicenter 
clinical studies, as well as future prospective and 
controlled studies are needed to both estimate the 
true incidence and prevalence of RCIN and to 
estimate its financial burden on Malaysian 
hospitals. Moreover, more future prospective and 
controlled studies are needed to find the ideal 
preventive treatment for nephropathy induced by 
radiocontrast media after different procedures 
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